What the Science of Blue Zones Actually Shows vs. What Wellness Brands Sell
The longevity data behind the original regions is contested and the habits are well supported, while the products sold under the label rest on far thinner evidence.
Blue zones research supports a pattern of plant-heavy eating, daily movement, strong social ties, and a sense of purpose.
Its headline claims about extreme longevity in specific regions rest on contested birth records, and the commercial products sold under the brand add little evidence beyond what the habits themselves already offer.
Trending Now!!:
The distinction matters because the phrase now covers three different things: a demographic hypothesis about where people live longest, a set of lifestyle lessons drawn from those places, and a commercial ecosystem of books, courses, foods, and certified cities.
Each rests on a different quality of evidence, and wellness marketing routinely borrows the credibility of the first to sell the third.
Where the Blue Zones Idea Came From
The term did not begin with a lifestyle brand. It first appeared in an academic paper on longevity in Sardinia, Italy, published in 2004, the work of demographers Gianni Pes and Michel Poulain, who reportedly marked high-longevity villages on a map with blue ink.
Dan Buettner, an explorer and author, later popularised the concept, working with National Geographic to identify five regions: Sardinia, Okinawa, Nicoya in Costa Rica, Ikaria in Greece, and Loma Linda in California.
From those regions, Buettner distilled nine shared habits and called them the Power 9. He went on to publish a bestselling book in 2008 and helped found the Blue Zones Project, which works with communities to recreate some of the conditions found in these places. A 2023 Netflix series extended the reach further.
The sequence is worth noting. A peer-reviewed demographic observation became a popular book, then a community program, then a consumer brand. Scientific scrutiny has tended to follow the marketing rather than lead it.
The Data Problem at the Core
The strongest challenge comes from Saul Justin Newman, a researcher at University College London’s Centre for Longitudinal Studies.
Newman analysed United Nations mortality statistics for 236 jurisdictions and argues that clerical errors, pension fraud, and missing birth and death records explain much of the apparent longevity. His work earned an Ig Nobel Prize in the demography category, an award that honours research that makes people laugh and then think, and carries no verdict on correctness.
His specific claims are pointed. Records in Okinawa were largely destroyed in the Second World War and then poorly managed under American occupation.
A study in Costa Rica found that 42 percent of centenarians had misreported their age in an earlier census. Newman has also argued that extreme old age correlates with poverty and weak record-keeping, suggesting that longevity is very likely tied to wealth, which is the opposite of what a blue zone narrative implies.
The defenders have answered. Several prominent blue zone researchers called Newman’s work “ethically and academically irresponsible”, and argued that he analysed broad regions of Japan and Sardinia when the blue zones were much smaller areas.
A peer-reviewed response, published in The Gerontologist, defends the demographic validation of the original sites. Newman counters that this geographic argument illustrates his point about unreliable local records.
Independent expertise points in both directions. Aging researcher Steve Horvath, who developed an epigenetic clock to validate claims of exceptional longevity, described Newman’s analysis as rigorous and convincing, while noting that several blue zones are overseen by careful scientists.
A fair reading is that the demographic record is weaker than the marketing implies, and that the dispute is unresolved rather than settled in either direction.
The Loma Linda Admission
One detail deserves more attention than it usually receives. Buettner has acknowledged that Loma Linda was something of an outlier, added to the original National Geographic article because his editor told him, “you need to find America’s blue zone”.
Loma Linda is a community built around Seventh-day Adventist religious practice, with its own dietary teachings and a large body of dedicated research. It is not a remote village where centenarians accumulated through geography and tradition.
Its inclusion shows how the list was curated for narrative reasons as well as demographic ones, and why the phrase “five blue zones” describes an editorial selection more than a systematic global survey.
What the Evidence Still Supports
Dismissing the entire framework would be as careless as accepting it whole. Longevity researchers still endorse the practices that the blue zones research helped identify.
Cardiologist and researcher Eric Topol has noted that the core themes, including a diet built on whole grains, beans, nuts, and greens, physical activity, social engagement, and a sense of purpose, are backed by randomized trials or large prospective studies independent of any blue zone.
This is the critical separation. The habits are supported by general nutrition, cardiology, and gerontology research. The claim that specific villages produce centenarians at ten times the American rate is a separate demographic assertion, and it can be wrong without making the habits wrong.
Two cautions apply even to the habits. The Power 9 includes moderate, regular alcohol consumption in every blue zone except among Adventists, and research over the past decade has weakened the case for alcohol as protective, so this is the element least worth copying.
The second concerns genetics. The Danish twin study that anchors the research suggested that roughly 20 percent of longevity is dictated by genes. Still, that figure comes from a specific population and period, and it says little about how much any individual can change by adopting a diet.
Where the Marketing Departs From the Research
The commercial layer is where the distance from the evidence grows widest. Critics point to a catalogue that has included cooking courses, recipe collections, coffee, tea, hot sauce, and skincare items carrying the blue zones label. Buettner trademarked the phrase in 2005 and sold the Blue Zones brand to Adventist Health in 2020.
No study shows that a branded coffee or a packaged meal reproduces the longevity of a Sardinian shepherd. The original observation concerned patterns of living across decades: walking hills, eating home-cooked beans, belonging to a community, and not sitting in front of a screen. A product can imitate a menu but not a lifestyle.
The brand has also moved into place-making. Roughly 80 US locales participate in Blue Zones Project initiatives, some funded by health systems and insurers, with measures such as bike paths and smoking bans.
These interventions have a plausible public health logic, and Buettner has defended the community model as separate from the contested demographics. Real estate developments using the label have raised questions about whether the designation signals healthy design or serves as a marketing gimmick.
The community results he cites deserve scrutiny too. A project in Albert Lea, Minnesota, reportedly increased average life expectancy by 2.9 years, a figure Buettner calculated himself. A modeled projection by the program’s own founder is a different kind of evidence than an independently measured mortality outcome.
A Practical Framework for Judging Any Blue Zones Claim
Four questions separate reliable claims from marketing.
The first is whether the claim concerns a habit or a product. Habits such as eating beans, walking daily, and maintaining close relationships have independent support. A branded item needs its own evidence.
The second is whether the supporting evidence is demographic or experimental. Birth-record claims about centenarians face the data quality issues described above. Trial and cohort evidence about diet and activity does not depend on them.
The third is who benefits from the conclusion. A recommendation to eat more legumes costs the reader almost nothing, while a recommendation to purchase a certified program or branded line carries a revenue interest.
The fourth is whether the size of the promised effect matches the quality of the data. Claims of added years of life expectancy from a single food or practice rest on observational associations, which cannot separate the food from everything else in the eater’s life.
What to Take From It
The defensible takeaway is modest and cheap. A diet centered on legumes, vegetables, whole grains, and nuts; regular low-intensity movement built into the day; durable social ties; and a reason to get up in the morning align with the best available evidence on healthy aging, regardless of whether Okinawa or Sardinia holds the record for centenarians.
Readers who spend money on longevity should follow the same logic. Supplements, certified programs, and premium food products need evidence that stands alone, because the blue zones label does not provide it.
The unresolved data dispute is a reason for caution about the story and no reason to abandon the habits, which never needed a brand to be worth adopting.
What People Ask


